Next Science Ltd (NXS) - Total Liabilities

Latest as of June 2025: AU$10.02 Million AUD ≈ $7.09 Million USD

Based on the latest financial reports, Next Science Ltd (NXS) has total liabilities worth AU$10.02 Million AUD (≈ $7.09 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Next Science Ltd (NXS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Next Science Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Next Science Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Next Science Ltd.

Next Science Ltd Competitors by Total Liabilities

The table below lists competitors of Next Science Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Quilter PLC LSE:QLT	UK	GBX86.36 Billion
Quantum Cyber N.V. NASDAQ:QUCY	USA	$3.13 Million
UTI Inc KQ:179900	Korea	₩114.22 Billion
China Crystal New Material KQ:900250	Korea	₩21.94 Billion
Shanghai Lingyun Industries Development Co Ltd SHG:900957	China	$423.71 Million
CTK Co. Ltd KQ:260930	Korea	₩111.40 Billion
V-Tac Technology Co Ltd TWO:6229	Taiwan	NT$1.13 Billion
Wattana Karnpaet Public Company Limited BK:NEW	Thailand	฿110.88 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Next Science Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Next Science Ltd (NXS) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-17.98	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Next Science Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Next Science Ltd (2016–2024)

The table below shows the annual total liabilities of Next Science Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$5.77 Million ≈ $4.08 Million	+13.63%
2023-12-31	AU$5.08 Million ≈ $3.59 Million	-22.14%
2022-12-31	AU$6.52 Million ≈ $4.62 Million	+121.78%
2021-12-31	AU$2.94 Million ≈ $2.08 Million	-37.37%
2020-12-31	AU$4.70 Million ≈ $3.32 Million	+40.70%
2019-12-31	AU$3.34 Million ≈ $2.36 Million	+36.73%
2018-12-31	AU$2.44 Million ≈ $1.73 Million	+336.36%
2017-12-31	AU$559.46K ≈ $395.85K	+125.39%
2016-12-31	AU$248.22K ≈ $175.63K	--

About Next Science Ltd

AU:NXS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$30.02 Million

AU$42.43 Million AUD

Market Cap Rank

#23875 Global

#929 in Australia

Share Price

AU$0.15

Change (1 day)

+0.00%

52-Week Range

AU$0.14 - AU$0.16

All Time High

AU$4.60